Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1989-5-18
|
pubmed:abstractText |
The effects of 3-glucosaminoglycan sulfate on lipids and the hemorheologic parameters were observed in a preliminary double-blind crossover study in 30 hyperlipidemic peripheral vascular disease (PVD) patients. Parenteral administration of the test drug was associated with a reduction in serum lipids, especially in triglyceride levels, and a lowering of fibrinogen, plasma viscosity, and whole blood viscosity levels. These effects justify the drug's use in the treatment of PVD, especially when associated with hypertriglyceridemia and hemorheologic disturbances.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-3197
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2705632-Adult,
pubmed-meshheading:2705632-Arteriosclerosis,
pubmed-meshheading:2705632-Blood Viscosity,
pubmed-meshheading:2705632-Double-Blind Method,
pubmed-meshheading:2705632-Female,
pubmed-meshheading:2705632-Fibrinogen,
pubmed-meshheading:2705632-Glycosaminoglycans,
pubmed-meshheading:2705632-Humans,
pubmed-meshheading:2705632-Hyperlipidemias,
pubmed-meshheading:2705632-Lipids,
pubmed-meshheading:2705632-Male,
pubmed-meshheading:2705632-Middle Aged
|
pubmed:year |
1989
|
pubmed:articleTitle |
Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
|
pubmed:affiliation |
2nd Department of Internal Medicine, Perugia University, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|